Skip to main content
. 2021 Apr 15;35:279–294. doi: 10.1016/j.jare.2021.04.003

Table 1.

Liver Parameters Affected by PFOA Hepatotoxicity for the Control, PFOA Treatment, and PFOA + VC Treatment Sample Groups.

Parameters Control PFOA VC + PFOA
Body mass (g) 45.65 ± 2.06 44.83 ± 2.16 43.23 ± 3.72
Liver mass (g) 1.56 ± 0.12 3.71 ± 0.18a 2.35 ± 0.24b
Liver index (%) (liver/body weight × 100%) 3.67 ± 0.21 8.9 ± 0.4a 5.73 ± 0.4b
Fasting blood glucose (mmol/L) 4.7 ± 0.5 6.4 ± 1.2 4.8 ± 0.8
Total cholesterol (mmol/L) 3.11 ± 0.15 6.6 ± 0.14a 3.25 ± 0.26b
Triglyceride (mmol/L) 0.68 ± 0.06 1.07 ± 0.25a 0.74 ± 0.05b
Alanine aminotransferase (U/L) 8.71 ± 0.76 17.26 ± 1.18a 11.48 ± 0.45b
Aspartate aminotransferase (U/L) 12.67 ± 1.93 29.28 ± 1.52a 19.02 ± 1.38b
Low density lipoprotein (mmol/L) 0.22 ± 0.03 0.35 ± 0.05 0.15 ± 0.05b
High density lipoprotein (mmol/L) 7.99 ± 0.86 3.24 ± 0.72a 4.94 ± 0.24b
Hepatic lipase (μg/mL) 126.16 ± 15.82 129.85 ± 21.9 161.93 ± 6.97b

Note: Paired Student’s t test (GraphPad Prism 3.02); aP<0.05 vs control; bP<0.05 vs PFOA.